Obagi appears in The Acne Brief through CLENZIderm Pore Therapy. The company also offers other product categories, but they are outside the conclusion of this focused entry. Keeping the product name visible avoids transferring a prescription’s status or another formula’s evidence to a retail liquid.
The official product and refund pages were checked on October 14, 2026. We did not buy or apply Pore Therapy and did not evaluate an individual’s skin. This profile connects the brand listing to the more detailed formulation, evidence and purchase questions in its product review.
The selected liquid has an identifiable active
Pore Therapy declares 2% salicylic acid in a leave-on format. The supporting list includes SD Alcohol 40-B, fragrance and menthol, which deserve consideration beside the active percentage. The label does not predict the exact experience of every person using it. [1]
Our Pore Therapy brief distinguishes that preparation from a cleanser, cream or custom blend. A familiar brand and matching percentage do not establish identical vehicles, compatibility or clinical performance across those different forms.
The manufacturer evidence retains its date and type
Consumer material is attributed to 2024 data on file. That remains the source’s stated evidence date even though this publication checked the page in October 2026. We did not independently appraise a complete study protocol or convert consumer impressions into a controlled comparative result. [1]
The direct listing displayed $50, with personal checkout charges and inventory unverified. Refund terms describe a thirty-day delivery-based period and exclusions, including final-sale samples and shipping costs. A different retailer’s agreement may differ, and no completed return was tested here. [2]
The entry informs a question rather than a regimen
AAD new-product guidance gives general context for considering a formula’s effect on skin. It does not approve this particular liquid or show that it belongs with every existing acne treatment. The actual preparation and relevant history are needed for an individual discussion. [3]
CoreAge Rx’s commercial feature does not demonstrate that its product is superior to Pore Therapy. Obagi’s brand recognition likewise supplies no missing head-to-head evidence. The directory keeps both the published facts and the limits of this source-based review visible.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Acne Toner & Pore-Reducing Therapy | Obagi Pore TherapyOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Refund policy – ObagiOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- How to test skin care productsIndependent clinical or regulatory context · Checked October 14, 2026